Skip to main content
Clinical Trials/DRKS00016795
DRKS00016795Completed未知

Perioperative assessment of the remnant liver functional capacity with the 13C methacetin breath test - ReLiF study

Allgemein- und Viszeralchirurgie Asklepios Klinik Barmbek0 sites30 target enrollmentStarted: February 21, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • All adult patients (> 18 years of age) able to give consent, who will undergo a liver resection of 3 or more liver segments according to Couinaud classification at the Department of General and Visceral Surgery of the Asklepios Klinik Barmbek within one year of the study beginning.

Exclusion Criteria

  • 1. Patients with an allergy to acetaminophen or methacetin.
  • 2. Patients who have received a strong CYP1A2 agonist (e.g., ciprofloxacin, fluvoxamine, enoxacin, verapamil) within the half-life of these substances

Investigators

Sponsor
Allgemein- und Viszeralchirurgie Asklepios Klinik Barmbek

Similar Trials